LSM3212 - Lecture 2-4 Blood
LSM3212 - Lecture 2-4 Blood
LSM3212 - Lecture 2-4 Blood
A/Prof CT Wong
LSM3212 Blood
A/Prof CT Wong
LSM3212 Blood
BLOOD Composition of blood: plasma and cellular elements of blood ll l l t f bl d Functions of Blood Blood Cells and their Production Hemostasis: prevention of blood loss e ostas s: p eve t o o b ood oss
A/Prof CT Wong
LSM3212 Blood
Cells
A/Prof CT Wong
LSM3212 Blood
Composition of blood p
A/Prof CT Wong
LSM3212 Blood
Components of plasma
Protein concentrations: i i
Total Albumin Globulins Gl b li Fibrinogen Transferrin 6.0-8.0 g/dL 3.1-4.3 g/dL 2.6-4.1 g/dL 2 6 4 1 /dL 200-450 mg/dL 3.0-6.5 mg/dL
All the plasma proteins are synthesized in liver except immunoglobulins, from Blymphocytes.
A/Prof CT Wong
LSM3212 Blood
thrombocytes
reticulocytes
A/Prof CT Wong
LSM3212 Blood
A/Prof CT Wong
LSM3212 Blood
Erythrocytes Males Females Total WBC Granulocytes Neutrophils Eosinophils Basophils Lymphocytes Monocytes Platelets
3000 6000 150 300 10 - 100 1500 4000 300 600 200,000 500,000
50 70 14 0.4 20 - 40 2-8
A/Prof CT Wong
LSM3212 Blood
11
Measures
Percentage of formed elements in whole blood. Circulating percentage of reticulocytes Concentration of hemoglobin in blood Number of RBCs per l of whole blood Male
Elevated values l
Polycythemia Reticulocytosis
Depressed values l
Anemia
40 to 54 14 to 17
~0.8%
LSM3212 Blood 12
Functions
Transport/Distribution
Oxygen and carbon dioxide Metabolic wastes Various substances (eg. minerals, vitamins, etc)
Homeostasis/Regulation
Body temperature pH H Fluid volume
Protection
Against blood loss (Hemostasis) Against infection (Immunology) *
A/Prof CT Wong
LSM3212 Blood
13
Immune system Leukocytes are the mobile units of the bodys immune system. They function mainly as defense agents outside the blood. They defend against the invasion of pathogens. They identify cancer cells. They remove the bodys litter by phagocytosis. They can leave the circulation and go to the sites of invasion and tissue damage damage.
LSM3223 Immunology I l
A/Prof CT Wong LSM3212 Blood
#09
14
A/Prof CT Wong
15
Hb = hemoglobin
A/Prof CT Wong LSM3212 Blood 16
Transport of oxygen
A/Prof CT Wong
LSM3212 Blood
17
Hemoglobin function
1 Hb molecule = 4 Hb chains 1 Hb chain = 1 heme + 1 globin
abm3s6a.mov
A/Prof CT Wong LSM3212 Blood 18
A/Prof CT Wong
LSM3212 Blood
20
[carbaminoHb]
(~7%) (~70%)
(~23%)
A/Prof CT Wong
LSM3212 Blood
21
Nutritional requirements
General (proteins, carbohydrates, lipids) Vitamins (Vitamin B12, folate, others) Minerals (iron, others)
H Hemoglobin synthesis l bi th i
Heme synthesis Iron metabolism H Heme catabolism t b li
A/Prof CT Wong LSM3212 Blood 22
A/Prof CT Wong
A/Prof CT Wong
A/Prof CT Wong
Globin synthesis
Type of globin chain determines type of hemoglobin hemoglobin. Each consist of a tetramer of globin polypeptide chains., each with an attached heme. -like chains 141 aa long -like chains 146 aa long HbF (), fetal Hb HbA (), adult Hb HbA2 ( ) adult Hb, normal (), d l Hb l variant, very small %. HbS () abn aa6 glu-val glu val HbE () abn aa26 glu-lys
A/Prof CT Wong
LSM3212 Blood
27
Iron metabolism
Iron absorption occurs predominantly in the duodenum and upper jejunum. Iron must traverse both the apical and basolateral membranes of absorptive epithelial cells to reach the plasma. This transport requires enzymes that change plasma the oxidation state of iron. Iron that is present in food (particularly in red meat, pulses (legumes) and dairy p products) primarily occurs as Fe(III) or as heme. There is evidence that heme )p y ( ) may be transported into the intestine by a specific carrier (heme carrier protein 1; HCP1) although the nature of the carrier is unknown. Iron from heme is better absorbed compared to non-heme iron. Iron that is exported from cells into plasma by ferroportin becomes bound to transferrin, 80-kDa transferrin an 80 kDa glycoprotein with homologous N terminal and C terminal N-terminal C-terminal iron-binding domains that is synthesized in the liver, retina, testis and brain. At the neutral pH of blood, transferrin can bind two atoms of Fe(III) with a ( ) ( ) y dissociation constant (Kd) of 1023 M. Fe(III) binds transferrin only in the presence of an anion, usually carbonate, that bridges iron and transferrin.
A/Prof CT Wong LSM3212 Blood 28
Iron transport across the enterocyte (mucosal cells lining the internal wall of the intestines).
Amount of available iron is dependent on p (1)Amount of iron in food we ingest main source is meat (2)Form of iron present in the food
Ferric iron (Fe(III)) in the diet is converted to ferrous iron (Fe(II)) by a ferroreductase (DCYTB, duodenal cytochrome B) that is located on the apical surface of enterocytes of the duodenal mucosa.
Amount of iron absorbed is well controlled by feedback system (many hypotheses, no complete agreement), absorbing enough to balance daily loss. loss Liver stores a ready supply of iron.
A/Prof CT Wong LSM3212 Blood 30
Endocytosis of the complex of iron, transferrin and the transferrin receptor. The plasma protein transferrin (Tf) binds Fe(III) with high affinity. At the neutral pH (7.2) in plasma, TfFe(III) binds to the transferrin receptor (TfR) on the cell surface from where it is internalized by receptormediated endocytosis through clathrin-coated pits. The internalized vesicle (an endosome) becomes acidified (pH 5.5) by the action of an H+ ATPase (not shown). As the p of the endosome decreases, the structure of the ( ) pH , TfTfR complex changes and Fe(III) is released from TfFe(III). Fe(III) is converted to Fe(II) by the endosomal reductase STEAP3 (six-transmembrane epithelial antigen of the prostate 3) and is then transported out of the endosome into the cytosol by divalent metal transporter-1 (DMT1) F (II) can b stored i f iti i nonerythroid cells or incorporated t t 1 (DMT1). Fe(II) be t d in ferritin in th id ll i t d into haemoglobin in erythroid cells. The TfTfR complex is exocytosed by a recycling endosome.
A/Prof CT Wong LSM3212 Blood 31
In liver
In maturing rbc
A/Prof CT Wong LSM3212 Blood 32
1* ALA synthase; 2 PBG synthase/ALA dehydratase; 3 PBG deaminase/Uroporphyrinogen III synthase; 4 Uroporphyrinogen decarboxylase; 5 coproporphyrinogen III oxidase; 6 protoporphyrinogen IX oxidase; 7 Ferrochelatase (Addition of iron occurs at this step)
A/Prof CT Wong LSM3212 Blood 33
Heme Catabolism
The largest repository of heme in the human body is in red blood cells, which have a life span of about 120 days. There is thus a f b t d Th i th turnover of about 6 g/day of hemoglobin, which presents 2 problems. Breakdown of rbc normally occurs in the reticuloendothelial system, mainly in the spleen and liver (Kupffer cells). First, the porphyrin ring is hydrophobic and must be solubilized to be excreted. Second, iron must be conserved for new heme synthesis. Normally, senescent red blood cells and heme from other sources are engulfed by cells of the reticuloendothelial system. The globin is recycled or converted into amino acids, which in turn are recycled or catabolized as required. I i d Iron i released into the circulation is l d i t th i l ti for reuse by the body.
A/Prof CT Wong
LSM3212 Blood
34
Heme i oxidized, with the heme ring being opened by the H is idi d i h h h i b i db h endoplasmic reticulum enzyme, heme oxygenase. The oxidation step requires heme as a substrate, and any hemin (Fe3+) is reduced to heme (Fe2+) prior to oxidation by heme oxygenase. oxygenase
A/Prof CT Wong
LSM3212 Blood
35
In the next reaction a second bridging methylene (between rings III and IV) is reduced by biliverdin reductase, producing ,p g bilirubin. Bilirubin is released into the circulation. It is transported in the plasma bound to albumin. This is the free or unconjugated bilirubin, and it is quite insoluble.
A/Prof CT Wong
LSM3212 Blood
36
Albumin bound bilirubin is transport to hepatocytes, where UDP glucuronyl transferase adds 2 equivalents of glucuronic acid to bilirubin to produce the more water soluble, bilirubin diglucuronide derivative. The increased water solubility of Th i d l bili f the tetrapyrrole facilitates its excretion with the remainder of the bile as the bile pigments pigments.
A/Prof CT Wong
LSM3212 Blood
37
A/Prof CT Wong
38
Jaundice
In normal individuals, intestinal bilirubin is acted on by individuals bacteria to produce the final porphyrin products, urobilinogens and urobilins, that are found in the feces. Bilirubin and its catabolic products are collectively known as the bile pigments. In individuals with abnormally high red cell lysis, or liver y g y , damage or obstruction of the bile duct, the bilirubin and its precursors accumulate in the circulation; the result is hyperbilirubinemia, hyperbilirubinemia the cause of the abnormal body pigmentation known as jaundice.
A/Prof CT Wong
LSM3212 Blood
39
Anemia
Anemia is a reduction below the normal capacity in the blood to carry oxygen. Th are many kinds of anemia. There ki d f i Nutritional anemia is caused by a dietary deficiency of a factor needed for erythropoiesis (eg. iron, vitamins). Aplastic anemia is due to the failure of the bone marrow to make adequate numbers of RBCs. Renal anemia is due to kidney disease; lack of Epo. Hemorrhagic anemia is due to the loss of significant amounts of blood (and production cannot keep up with loss). Hemolytic anemia is due to the rupture of many RBCs. Sickle cell y p y disease can make red cells fragile and vulnerable to hemolysis.
PRODUCTION vs LOSS/DESTRUCTION
A/Prof CT Wong LSM3212 Blood 40
Polycythemia
Polycythemia is an excess in circulating erythrocytes. Normal indication is an elevated hematocrit or hemoglobin levels. levels Primary polycythemia is caused by an tumor-like condition in the bone marrow. Secondary polycythemia is an erythropoietin induced adaptive erythropoietin-induced mechanism to improve the oxygen-carrying capacity in the blood. Relative (spurious) polycythemia: Other conditions can elevate the hematocrit, hematocrit such as dehydration or a decrease in plasma volume. volume
PRODUCTION vs LOSS/DESTRUCTION
A/Prof CT Wong LSM3212 Blood 41
Their rates change depending on the changing defense needs of the body. They are produced from pluripotent stem cells in the bone marrow. These cells can differentiate and proliferate into different cell lines, producing the different kinds of white blood cells. ll Granulocytes and monocytes are produced only in the bone marrow. Lymphocytes are originally produced from precursor cells in the bone marrow. Most new ones are produced from lymphocytes in lymphoid tissue (eg lymph nodes).
A/Prof CT Wong
LSM3212 Blood
42
Hemostasis e os s s
Primary hemostasis
V Vessel walls l ll Platelets
Coagulation
Coagulation factors Extrinsic pathway Intrinsic pathway Common pathway
C t l of hemostasis Control f h t i
Anticoagulants Fibrinolysis
A/Prof CT Wong LSM3212 Blood 43
Platelets releases numerous substances when activated. Some of these substances will enhance the aggregation process. A Among these are A h ADP, thromboxane A2, calcium h b A2 l i ions. Other substances from the endothelium of a blood vessel inhibit platelet aggregation, keeping the process under control control.
A/Prof CT Wong LSM3212 Blood 44
A/Prof CT Wong
LSM3212 Blood
45
A/Prof CT Wong
LSM3212 Blood
46
The clotting cascade is a series of steps involving twelve clotting factors. They lead to the final conversion of fibrinogen into fibrin.
The clotting factors serve as proteolytic enzymes in a series of ser e proteol tic en mes reactions, the clotting sequence. One factor in the sequence is activated which in turn activates another factor and so on. This sequence is called the clotting cascade. cascade The last two steps in the cascade are: prothrombin is converted to thrombin fib i fibrinogen is converted to fibrin i d fib i intrinsic pathway - This uses the sequence of factors in the cascade. extrinsic pathway - This requires only four steps and requires contact with tissue factors external to the blood.
A/Prof CT Wong
LSM3212 Blood
47
A/Prof CT Wong
Coagulation factors
*
I II III IV V VII VIII IX X XI XII XIII HMW-K Pre-K Ka PL Fibrinogen Prothrombin Thromboplastin/tissue factor Calcium Proacclerin, labile factor, accelerator globulin Proconvertin, SPCA, stable factor Antihemophilic factor (AHF), antihemophilic factor A, antihemophilic globulin (AHG) ih hili l b li Plasma thromboplastic component (PTC), Christmas factor, antihemophilic factor B Stuart-Prower factor Plasma thromboplastin antecedent (PTA), antihemophilic factor C Hageman factor, glass factor Fibrin-stabilizing factor, Laki-Lorand factor factor High-molecular-weight kininogen, Fitzgerald factor Prekallikrein, Fletcher factor Kallikrein Platelet h h li id Pl l phospholipid
* * *
Vitamin K acts as a cofactor in the formation of gcarboxyglutamyl residues (gla components) from g glutamyl residues (glu y (g components) in the coagulation factors listed. These residues are important in the formation of calcium binding sites. The next slide show the events that will h h h ill lead to the conversion of p prothrombin to thrombin.
A/Prof CT Wong
LSM3212 Blood
50
Coagulation cascade
Common pathway
(Prothrombin activator)
The figure on the left is the situation at the start of the common pathway. Factor Xas gla components are attracted to the ionised Ca that are in contact with platelet factor 3 (also called platelet phospholipids). These platelet phospholipids have negative charges that attract the Ca in the plasma. This builds up the concentration of Xa in the damaged area. Prothrombin, which also possesses gla components are also attracted by the Ca present. This thus increases its concentration and also brings it in close proximity with Xa (see figure on right). Xa then can act on the prothrombin and convert it to thrombin. Same sort of reaction occurs in the activation of factor X by IXa (intrinsic pathway) or VIIa (extrinsic). Next 2 slides show how inactive coagulation factors are activated mainly by loss of part of the protein molecule, change in 3D structure, exposure of active sites in the molecule.
52
(active site)
Figure on left is the normal circulating inactive factor X. Removal of part of the molecule by either IXa (intrinsic pathway) or VIIa complexes (extrinsic pathway) allows for changes in 3D conformation, leading to exposure of active site, converting it into an active enzyme. Similar events occur during activation of IX, VII and conversion of prothrombin to thrombin.
( = gla components)
A/Prof CT Wong LSM3212 Blood 53
(active site)
(Thrombin removes part of the fibrinogen molecule, which allows the fibrin monomer to bind to one another)
A/Prof CT Wong
LSM3212 Blood
54
Anticoagulants
Heparin/heparan
Heparin in plasma; heparan on endothelial surface Functions as co-factor to anti-thrombin III Normal constituent of plasma
Anti-thrombin III
Plasma protein that binds to and inactivates thrombin, IXa, Xa One of the many plasma proteins normally present in blood
Fibrinolysis
UPA = urinary PA/ urokinase PAI = PA inhibitor 2PI-Plasmin = plamin inhibitor FDPs = fibrin degradation products
A/Prof CT Wong
The clot is not a permanent solution for injury to a vessel. To ensure smooth i j l T h flow of blood in the vessels, clot will have to be removed. Fibroblasts form scar tissue for vessel repair. The clot is slowly dissolved by the enzyme plasmin. Plasminogen is made in the liver and is a plasma protein normally present in the circulation. At the site of damage, it is converted to g plasmin by tissue plasminogen activator (tPA), released from damage endothelial cells. Phagocytic white blood cells remove the products of clot dissolution.
LSM3212 Blood
56
http://www.mhhe.com/biosci/esp/2002_general/Esp/folder_str ucture/tr/m1/s7/trm1s7_3.htm / / / / h
A/Prof CT Wong
LSM3212 Blood
57
A/Prof CT Wong
LSM3212 Blood
58